Pioneers and Their Vision
ISPE Singapore was established by visionaries who recognized the need for a local Affiliate to support the region’s rapidly evolving pharmaceutical landscape. Founding members recall the challenges of building a strong foundation while promoting professional competence and training.
“Celebrating its 25th anniversary, ISPE Singapore stands as a pillar in advancing pharmaceutical engineering and technology,” said Geoff Brown, who served as the ISPE Singapore President from 2016 to 2018. “During my presidency, we focused on fostering education programs, enhancing professional competence, and integrating industry stakeholders. Growing to over 300 members with a 20-plus-member executive committee, we promoted dialogue and knowledge sharing through regular workshops and events. I’m particularly proud of the growth of our annual conference and exhibition, which has flourished into the leading pharma and life science event in Singapore.”
Singapore: A Global Pharma Hub
Over the past 25 years, Singapore has emerged as a global leader in pharmaceutical and biotechnology manufacturing, research, and regulatory excellence. The city-state’s strategic business environment and strong regulatory framework have positioned it as a hub for innovation. ISPE Singapore has been instrumental in supporting this growth by fostering collaboration between industry and regulators, offering training, and providing networking opportunities.
Bob Tribe, the Regulatory Advisor for ISPE Singapore, says of the Affiliate’s impact: “The close collaboration between the Affiliate and regulators has brought mutual benefits, fostering open communication and a deeper understanding between industry and regulatory authorities. This partnership enables the industry to better grasp regulatory requirements, ensuring product quality and compliance, while also providing regulators with insights into industry challenges and the latest technological advancements.”
Memorable Moments and Community Spirit
ISPE Singapore’s annual conference and events are cherished for their professional insights and the strong sense of community they nurture. Vee Revithi, a long-time Singapore Conference supporter, reflects on the Affiliate’s legacy: “It has been a long time since I started participating at the conferences and events as a regulator, as an industry representative, and as a consultant. Throughout those years, I found the conferences not only interesting and professional, but always very pleasant and satisfying, as people were happy to get together, learn, and communicate. The close collaboration between the Affiliate, regulators, and industry has brought mutual benefits, fostering open communication and a deeper understanding between them. And one more factor for the success: the kind and warm hospitality of the ISPE Singapore Affiliate, always finding solutions while keeping high professionalism.”
Reflecting on the early days, it is worth mentioning a notable event from 2001, when the founding CEO of the newly established Singapore Health Sciences Authority (HSA), Clarence Tan, PhD, and Sia Chong Hock, the founding Director of the GMP Audit Unit at HSA, served as keynote speakers at the inaugural ISPE Singapore Conference.
“The new regulator, namely the Health Sciences Authority, will adopt high standards but will not impede industry growth. It will be a health inspector that is industry-friendly,” Dr. Tan told the Business Times, a financial newspaper in Singapore.
Looking to the Future
As the pharmaceutical and biopharmaceutical industries continue to evolve, ISPE Singapore remains committed to addressing emerging challenges, including digital transformation, sustainability, and regulatory advancements. The Affiliate will continue to empower the next generation of leaders, fostering innovation while upholding the highest standards of quality and compliance.
Join the Celebration
As we celebrate 25 years of ISPE Singapore, we invite the global ISPE community to join us at the ISPE Singapore Annual Conference 27–29 August. Let us continue to shape the future of pharmaceutical engineering together, with Singapore at the forefront of industry excellence.
